Saint-Gobain adds high purity option to Sani-Tech line
Ultra-HP combines reinforced outer jacket with fully bonded FEP liner
Ultra-HP combines a tough outer jacket and hose comprising multiple layers of Sani-Tech Ultra platinum-cured silicone and 316L stainless steel helical wire reinforcement with a PharmaFluor FEP liner. The liner's smooth inner bore surface provides both optimal flow and ease of cleaning and sanitisation.
The PharmaFluor FEP liner is said to minimise bonding of biological materials and maintains fluid purity due to low TOCs, extractables and leachables. The liner is fully bonded to the silicone hose using a patented bonding technology, which helps ensure a high purity fluid path.
The company says the hose's overall light weight, low force to bend and exceptional flexibility make it suitable for a variety of applications, including bioprocessing, load cells, product transfer and steam-in-place/clean-in-place (SIP/CIP).
Sani-Tech Ultra-HP hose is made from USP Class VI compliant materials and certified to meet USP <88>, USP <87>, EP 3.1.9, ISO 10993, FDA 21 CFR 177.2600 and FDA 21 CFR 177.1550 requirements.
You may also like
Trending Articles
You may also like
Manufacturing
Domino demonstrates an integrated approach to next-generation coding at Interpack 2026
At Interpack 2026, Domino Printing Sciences (Domino) will focus on the key challenges manufacturers face as variable data printing enters a new era shaped by 2D codes, intelligent automation, sustainability, and growing traceability demands. Domino specialists will be available throughout the show to highlight integrated solutions designed to work together on the factory floor – developed in collaboration with key industry partners to help to reduce complexity, risk, and operational friction for manufacturers
Manufacturing
Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target
BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target
Manufacturing
Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair
Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to support its expanding integrated CDMO model